HK1007334A1 - Tissue plasminogen activator having zymogenic or fibrin specific properties - Google Patents

Tissue plasminogen activator having zymogenic or fibrin specific properties

Info

Publication number
HK1007334A1
HK1007334A1 HK98106560A HK98106560A HK1007334A1 HK 1007334 A1 HK1007334 A1 HK 1007334A1 HK 98106560 A HK98106560 A HK 98106560A HK 98106560 A HK98106560 A HK 98106560A HK 1007334 A1 HK1007334 A1 HK 1007334A1
Authority
HK
Hong Kong
Prior art keywords
zymogens
variants
zymogenic
plasminogen activator
tissue plasminogen
Prior art date
Application number
HK98106560A
Other languages
English (en)
Inventor
Stephen Anderson
William F Bennett
David Botstein
Deborah L Higgins
Nicholas F Paoni
Mark Zoller
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of HK1007334A1 publication Critical patent/HK1007334A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)
HK98106560A 1988-09-02 1998-06-25 Tissue plasminogen activator having zymogenic or fibrin specific properties HK1007334A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24085688A 1988-09-02 1988-09-02
US07/384,608 US5108901A (en) 1988-09-02 1989-07-24 Tissue plasminogen activator having zymogenic or fibrin specific properties
PCT/US1989/003755 WO1990002798A1 (en) 1988-09-02 1989-08-29 Tissue plasminogen activator having zymogenic or fibrin specific properties

Publications (1)

Publication Number Publication Date
HK1007334A1 true HK1007334A1 (en) 1999-04-09

Family

ID=26933781

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98106560A HK1007334A1 (en) 1988-09-02 1998-06-25 Tissue plasminogen activator having zymogenic or fibrin specific properties

Country Status (18)

Country Link
US (1) US5108901A (de)
EP (1) EP0457758B1 (de)
JP (1) JP2794028B2 (de)
KR (1) KR0148575B1 (de)
AT (1) ATE124452T1 (de)
AU (1) AU626323B2 (de)
CA (1) CA1341484C (de)
DE (1) DE68923298T2 (de)
DK (1) DK175958B1 (de)
ES (1) ES2018729A6 (de)
FI (1) FI109359B (de)
HK (1) HK1007334A1 (de)
HU (1) HU213922B (de)
IE (1) IE67508B1 (de)
IL (1) IL91306A (de)
NO (1) NO310778B1 (de)
NZ (1) NZ230509A (de)
WO (1) WO1990002798A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756093A (en) * 1985-04-22 1998-05-26 Genentech, Inc. Tissue plasminogen activator variants
US5736134A (en) * 1985-04-22 1998-04-07 Genentech, In.C Tissue plasminogen activator variants
GB8815135D0 (en) * 1988-06-24 1988-08-03 British Bio Technology Proteins & nucleic acids
DK395288D0 (da) * 1988-07-15 1988-07-15 Novo Industri As Proteiner
US5156969A (en) * 1988-09-02 1992-10-20 Genentech Inc. Tissue plasminogen activator variant with deletion of amino acids 466-470 having fibrin specific properties
US5714145A (en) * 1988-09-02 1998-02-03 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
US5262170A (en) * 1988-09-02 1993-11-16 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties and substituted at amino acid positions 296-299, DNA molecules encoding them, vectors, and host cells
DE69033699T2 (de) * 1989-03-06 2001-05-23 The Board Of Regents Of The University Of Texas System, Austin Gegenüber eigenen inhibitoren resistente t-pa mutanten
US5304482A (en) * 1989-03-06 1994-04-19 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors
US5866413A (en) * 1989-03-06 1999-02-02 Board Of Regents Of The University Of Texas System Pai-1 mutants
US5550042A (en) * 1989-03-06 1996-08-27 The Board Of Regents Of The University Of Texas System Serine protease mutants of the chymotrypsin superfamily resistant to inhibition by their cognate inhibitors and genes encoding the same and serine protease inhibitor mutants and genes encoding the same
AU664469B2 (en) * 1992-06-03 1995-11-16 Genentech Inc. Tissue plasminogen activator glycosylation variants with improved therapeutic properties
US5472692A (en) * 1993-07-02 1995-12-05 New England Deaconess Hospital Corporation Pro-urokinase mutants
US5877016A (en) 1994-03-18 1999-03-02 Genentech, Inc. Human trk receptors and neurotrophic factor inhibitors
US5656427A (en) * 1994-08-29 1997-08-12 Gen-Probe Incorporated Nucleic acid hybridization assay probes, helper probes and amplification oligonucleotides targeted to Mycoplasma pneumoniae nucleic acid
US5759775A (en) * 1994-10-27 1998-06-02 Genetech, Inc. Methods for detecting nucleic acids encoding AL--1 neurotrophic factor
ZA966663B (en) 1995-08-17 1998-02-06 Genentech Inc Traf Inhibitors.
US6610296B2 (en) 1995-10-26 2003-08-26 Genentech, Inc. Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin
CA2271697C (en) * 1996-11-12 2007-10-23 The Scripps Research Institute Tissue type plasminogen activator (t-pa) variants: compositions and methods of use
US6706504B1 (en) 1996-11-12 2004-03-16 The Scripps Research Institute Tissue type plasminogen activator (t-PA) variants: compositions and methods of use
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
US20040241645A1 (en) * 1997-01-31 2004-12-02 Genentech, Inc. O-fucosyltransferase
CA2277266A1 (en) 1997-01-31 1998-08-06 Genentech, Inc. O-fucosyltransferase
WO1999009184A1 (de) * 1997-08-13 1999-02-25 Roche Diagnostics Gmbh Plasminogenaktivator mit verbesserter zymogenität und verminderter fibrinbindung
WO1999009185A1 (de) * 1997-08-13 1999-02-25 Roche Diagnostics Gmbh Plasminogenaktivator mit verbesserter zymogenität
KR100408844B1 (ko) * 2000-07-29 2003-12-06 한국산업기술평가원 동물세포 발현벡터
US20060104969A1 (en) * 2004-08-16 2006-05-18 Massachusetts Institute Of Technology Compositions and methods for enhancing structural and functional nervous system reorganization and recovery
US8969295B2 (en) * 2006-04-14 2015-03-03 Massachusetts Institute Of Technology Identifying and modulating molecular pathways that mediate nervous system plasticity
EP2056852A4 (de) * 2006-07-27 2010-01-13 Centocor Ortho Biotech Inc Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
WO2015023830A1 (en) 2013-08-14 2015-02-19 Stc.Unm Treatment and prevention of stroke and other neurological disorders
EP3215221B1 (de) 2014-11-03 2020-02-26 Thrombolytic Science, LLC Verfahren und zusammensetzungen zur sicheren und wirksamen thrombolyse
WO2018232305A1 (en) 2017-06-16 2018-12-20 Thrombolytic Science, Llc Methods and compositions for thrombolysis

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0125269A1 (de) * 1982-11-11 1984-11-21 Beecham Group Plc Pharmazeutisch aktive verbindungen
DE3382389D1 (de) * 1982-12-14 1991-10-02 South African Inventions Plasminogenaktivator.
US4753879A (en) * 1984-08-27 1988-06-28 Biogen N.V. Modified tissue plasminogen activators
EP0201153A3 (de) * 1985-02-09 1987-10-07 Beecham Group Plc Modifiziertes Enzym und Verfahren zu dessen Herstellung
EP0199574B1 (de) * 1985-04-22 1991-10-23 Genentech, Inc. Plasminogenaktivator-Mutante des menschlichen Gewebes, Verfahren und Zwischenprodukte dafür und diese Mutante verwendende Zusammensetzungen
GB8528321D0 (en) * 1985-11-18 1985-12-24 Ciba Geigy Ag Modified fibrinolytic agents
AU605124B2 (en) * 1985-12-23 1991-01-10 Behringwerke Aktiengesellschaft Novel peptide plasminogen activators
DK43387A (da) * 1986-01-29 1987-07-30 Beecham Group Plc Fibrinolytisk enzym
JP2527454B2 (ja) * 1986-01-31 1996-08-21 ジェネティックス・インスチチュ−ト・インコ−ポレ−テッド 新しい血栓溶解タンパク質
IE81073B1 (en) * 1986-03-18 2000-01-12 Genentech Inc Modified human tissue-type plasminogen activator and its preparation
PT84589B (en) * 1986-04-02 1989-05-09 Beecham Group Plc Process for preparing a fibrinolytic enzyme
DK345087A (da) * 1986-07-11 1988-01-12 Novo Industri As Modificeret vaevsplasminogenaktivator
WO1988005081A2 (en) * 1986-12-30 1988-07-14 Cetus Corporation Novel plasminogen activator
GB8705377D0 (en) * 1987-03-07 1987-04-08 Beecham Group Plc Compounds
EP0292009A1 (de) * 1987-05-22 1988-11-23 Zymogenetics, Inc. Fibrinolytische Proteine
IE67036B1 (en) * 1987-06-04 1996-05-15 Zymogenetics Inc Tissue plasminogen activator analogs having modified growth factor domains
ATE110772T1 (de) * 1987-06-04 1994-09-15 Zymogenetics Inc Mutierter t-pa mit kringle-ersatz.
SE8702562L (sv) * 1987-06-18 1988-12-19 Kabigen Ab Nya fibrinolytiska enzymer
WO1988010119A1 (en) * 1987-06-22 1988-12-29 Genetics Institute, Inc. Novel thrombolytic proteins
WO1989000191A1 (en) * 1987-07-06 1989-01-12 Genetics Institute, Inc. Novel thrombolytic proteins
AU1893988A (en) * 1987-07-13 1989-01-19 Collaborative Research Inc. Nonglycosylated plasminogen activator and method of preparation
DK395288D0 (da) * 1988-07-15 1988-07-15 Novo Industri As Proteiner

Also Published As

Publication number Publication date
IL91306A0 (en) 1990-03-19
AU4194689A (en) 1990-04-02
US5108901A (en) 1992-04-28
ATE124452T1 (de) 1995-07-15
NO310778B1 (no) 2001-08-27
IL91306A (en) 1997-08-14
NZ230509A (en) 1991-06-25
HUT58812A (en) 1992-03-30
FI109359B (fi) 2002-07-15
HU896005D0 (en) 1991-07-29
DE68923298D1 (de) 1995-08-03
HU213922B (en) 1997-11-28
NO910811L (no) 1991-02-28
DK175958B1 (da) 2005-08-29
IE67508B1 (en) 1996-04-03
IE892650L (en) 1990-03-02
JPH04500157A (ja) 1992-01-16
NO910811D0 (no) 1991-02-28
KR0148575B1 (ko) 1998-10-15
WO1990002798A1 (en) 1990-03-22
EP0457758A1 (de) 1991-11-27
CA1341484C (en) 2005-05-24
KR900702019A (ko) 1990-12-05
FI911049A0 (fi) 1991-03-01
AU626323B2 (en) 1992-07-30
EP0457758B1 (de) 1995-06-28
DK36991D0 (da) 1991-03-01
ES2018729A6 (es) 1991-05-01
DE68923298T2 (de) 1996-01-11
DK36991A (da) 1991-05-02
JP2794028B2 (ja) 1998-09-03

Similar Documents

Publication Publication Date Title
IE892650L (en) Tissue plasminogen activator having zymogenic or fibrin¹specific properties
Matsuda et al. A simple, large scale method for preparation of plasminogen-free fibrinogen
Etscheid et al. Activation of proPHBSP, the zymogen of a plasma hyaluronan binding serine protease, by an intermolecular autocatalytic mechanism
Paoni et al. Making tissue-type plasminogen activator more fibrin specific
Nieuwenhuizen Fibrinogen and its specific sites for modulation of t-PA induced fibrinolysis
Silverstein et al. Thrombospondin-plasminogen interactions: modulation of plasmin generation
Siigur et al. The direct actinc α-fibrin (ogen) olytic enzymes from snake venoms
DK0517756T3 (da) Vævs-plasminogenaktivator med fibrinspecifikke egenskaber
Gardell The search for the ideal thrombolytic agent: maximize the benefit and minimize the risk
Bachmann Fibrinolytic agents
Agnelli et al. Thrombolytic activity of two chimeric recombinant plasminogen activators (FK2tu-PA and K2tu-PA) in rabbits
Deguchi et al. Plasminogen activation by tissue plasminogen activator in the presence of platelets
Bode et al. New developments in thrombolytic therapy
Nieuwenhuizen et al. Species specificity in the acceleration of tissue-type plasminogen activator-mediated activation of plasminogens, by fibrinogen cyanogen bromide fragments
Gurewich Activation of fibrin-bound plasminogen by pro-urokinase and its complementariness with that by tissue plasminogen activator
DK0542869T3 (da) Vævsplasminogenaktivatorvarianter med nedsat udskillelse
Credo et al. Fibrinolytic mechanism, biochemistry, and preclinical pharmacology of recombinant prourokinase
ATE114170T1 (de) Substitutionsvariante des gewebeplasminogenaktivators.
Loscalzo Fibrinolytic therapy
AU608232B2 (en) Modified tissue plasminogen activator
Runge New horizons in the treatment of coronary artery thrombosis
Siigur et al. Polypeptides and proteins active in the coagulation process
Anderson et al. Tissue plasminogen activator having zymogenic or fibrin specific properties
Nelles et al. CHARACTERIZATION OF SINGLE CHAIN UROKINASE-TYPE PLASMINOGEN ACTIVATOR MUTANTS PRODUCED BY SITE-SPECIFIC MUTAGENESIS OF LYS
Anderson et al. Method for identifying tissue plasminogen activator having zymogenic or fibrin specific properties

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20090828